Trevi Therapeutics (TRVI) Return on Invested Capital [ROIC] (2020 - 2023)
Trevi Therapeutics (TRVI) reported Return on Invested Capital [ROIC] of -30.19% for Q3 2023, up 2.34 percentage points from -32.54% a year earlier but down 2.21 percentage points from the prior quarter.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Return on Invested Capital [ROIC] (2020 - 2023) Analysis & Trends
For FY2022, Trevi Therapeutics posted Return on Invested Capital [ROIC] of -40.32%, up 48.85 percentage points from FY2021.
- By year, Return on Invested Capital [ROIC] came in at -89.17% in FY2021 (-21.37 pp) and -67.80% in FY2020.
- Five-year quarterly Return on Invested Capital [ROIC] spans a low of -115.78% in Q3 2021 and a high of -25.17% in Q4 2022.
- Year over year, Return on Invested Capital [ROIC] has now increased in each of the last six quarters, with an average year-over-year change of +31.94 percentage points over the last eight quarters.
- The high point for year-over-year Return on Invested Capital [ROIC] in five years was Q4 2022 (a gain of 88.17 percentage points); the low point was Q4 2021 (a drop of 41.71 percentage points).
- Per Business Quant data, the three quarters before Q3 2023 came in at -27.98% (Q2 2023), -25.91% (Q1 2023) and -25.17% (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Trevi Therapeutics | 1.98 Bn | 1.98 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -30.19% |
| Jun 30, 2023 | -27.98% |
| Mar 31, 2023 | -25.91% |
| Dec 31, 2022 | -25.17% |
| Sep 30, 2022 | -32.54% |
| Jun 30, 2022 | -61.67% |
| Mar 31, 2022 | -111.99% |
| Dec 31, 2021 | -113.35% |
| Sep 30, 2021 | -115.78% |
| Jun 30, 2021 | -96.56% |
| Mar 31, 2021 | -80.78% |
| Dec 31, 2020 | -71.64% |
API Access
Trevi Therapeutics Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();